HR Stock Forecast & Price Target

Healthcare Realty Trust is supported by a durable outpatient-focused portfolio that benefits from essential hospital-linked demand, institutional capital interest, and the defensive nature of medical office buildings. Its HR 2.0 strategy is strengthening health system relationships and improving portfolio quality through targeted redevelopments, JV expansion, and selective acquisitions, with a $392 million development and redevelopment pipeline expected to contribute about $0.05/share of earnings accretion once stabilized. Financially, the company’s reported FFO estimates were lifted to $1.64/share in 2026, $1.69/share in 2027, and $1.76/share in 2028, while net debt to EBITDA of 5.6x and roughly $75 million of annual cash flow support a more flexible and resilient balance sheet.

Healthcare Realty Trust is viewed with a negative outlook because the proposed transaction appears to offer only a modest 10.5% premium and still sits 19% below implied NAV, suggesting limited value realization for shareholders. The analysis argues the deal’s attractiveness depends on 1x-1.5x GO REIT multiple expansion, and without that rerating the takeout metrics remain underwhelming versus historical and sector benchmarks. In addition, downside risks from macro conditions, healthcare regulation, operational disruptions, $300 million of lease-up spending, and $1.2 billion of asset sales at potentially higher cap rates could pressure earnings growth and dilute value.